Abstract
The decline in NO2 and PM2.5 pollutant levels were observed during COVID-19 around the world, especially during lockdowns. Previous studies explained such observed decline with the decrease in human mobility, whilst overlooking the meteorological changes (e.g., rainfall, wind speed) that could mediate air pollution level simultaneously. This pitfall could potentially lead to over-or under-estimation of the effect of COVID-19 on air pollution. Consequently, this study aims to re-evaluate the impact of COVID-19 on NO2 and PM2.5 pollutant level in Singapore, by incorporating the effect of meteorological parameters in predicting NO2 and PM2.5 baseline in 2020 using machine learning methods. The results found that NO2 and PM2.5 declined by a maximum of 38% and 36%, respectively, during lockdown period. As two proxies for change in human mobility, taxi availability and carpark availability were found to increase and decrease by a maximum of 12.6% and 9.8%, respectively, in 2020 from 2019 during lockdown. To investigate how human mobility influenced air pollutant level, two correlation analyses were conducted: one between PM2.5 and carpark availability changes at regional scale and the other between NO2 and taxi availability changes at a spatial resolution of 0.01°. The NO2 variation was found to be more associated with the change in human mobility, with the correlation coefficients vary spatially across Singapore. A cluster of stronger correlations were found in the South and East Coast of Singapore. Contrarily, PM2.5 and carpark availability had a weak correlation, which could be due to the limit of regional analyses. Drawing to the wider context, the high association between human mobility and NO2 in the South and East Coast area can provide insights into future NO2 reduction policy in Singapore.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
